Net direct tax collection grows 15.41% to ₹12.11 lakh crore till Nov 10
The Hindu
Net direct tax collection grew 15.41% to ₹12.11 lakh crore, surpassing the government's budgeted target for the fiscal year.
Net direct tax collection grew 15.41% to ₹12.11 lakh crore between April 1 and November 10.
This include net corporate tax of ₹5.10 lakh crore and non-corporate taxes (including taxes paid by individuals, HUFs, firms) of ₹6.62 lakh crore. Other taxes (which include Equalisation Levy and gift tax) worth ₹35,923 crore were mopped up.
As per the Central Board of Direct Taxes (CBDT) data, the gross collection of direct tax stood at ₹15.02 lakh crore, up 21.20%, during April-November 10.
Refunds worth ₹2.92 lakh crore was issued during the period, a 53% jump over year-ago period.
After adjusting for refunds, net direct tax collection (which include corporate, non-corporate and other taxes) stood at about ₹12.11 lakh crore, a 15.41% growth over ₹10.49 lakh crore mopped up in the same period last fiscal.
The government has budgeted to collect ₹22.12 lakh crore in the current fiscal from direct taxes (personal income tax, corporate tax and other taxes), up 13% over previous fiscal.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
India's industrial output rebounds with 3.1% growth in September, led by manufacturing, despite weak electricity and mining sectors.
India's retail inflation hits 6.2% in October, driven by a 10.9% spike in food prices, breaching RBI's upper limit.